Acknowledgments

In addition to being shaped by the research literature listed in the section References, the development of the SEQDESIGN and SEQTEST procedures has benefited significantly from the advice and expertise of the following researchers:

• Lu Cui, Eisai Medical Research

• Alex Dmitrienko, Eli Lilly

• Scott Emerson, University of Washington

• Gordon Lan, Johnson & Johnson

• Steve Snapinn, Amgen

• John Whitehead, University of Reading

The time and effort that these researchers have contributed is gratefully acknowledged.